Cas:203934-58-1 tert-butyl 4-(pyrrolidin-1-ylmethylidene)piperidine-1-carboxylate manufacturer & supplier

Chemical Name:tert-butyl 4-(pyrrolidin-1-ylmethylidene)piperidine-1-carboxylate

CAS.NO:203934-58-1

Synonyms:tert-butyl 4-(pyrrolidin-1-ylmethylidene)piperidine-1-carboxylate

Molecular Formula:C₁₅H₂₆N₂O₂

Molecular Weight:266.37900

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:32.78000

Exact Mass:266.19900

LogP:2.87280

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like tert-butyl 4-(pyrrolidin-1-ylmethylidene)piperidine-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 4-(pyrrolidin-1-ylmethylidene)piperidine-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl 4-(pyrrolidin-1-ylmethylidene)piperidine-1-carboxylate Use and application,tert-butyl 4-(pyrrolidin-1-ylmethylidene)piperidine-1-carboxylate technical grade,usp/ep/jp grade.

Related News: Founded in 1949 by Giovanni Stevanato, the packaging multinational is the world’s largest maker of cartridges for insulin pens and provides vials and syringes for 90% of the world’s Covid-19 vaccines. propa-1,2-dienylphosphonic acid manufacturers Zynteglo, a gene therapy for the blood disorder beta thalassaemia, uses a viral vector (or modified virus) to deliver a working gene into the patient’s blood cells. 3-nitro-benzoic acid-(2-nitro-anilide) suppliers Additionally, because only small quantities of enzyme are required to catalyze a reaction, integrating them into production workflows can dramatically reduce raw material costs. In turn, these properties of enzymes translate to lower overall costs for manufacturing the final product. Further savings are realized through elimination of complicated protection/deprotection and activation steps, removal of the need for multiple, time-consuming purifications, and higher atom utilization to increase the percentage of reactants that become useful products. 2.2-Diaethyl-3-cyclopentyl-propionsaeure-nitril vendor & factory Zynteglo, a gene therapy for the blood disorder beta thalassaemia, uses a viral vector (or modified virus) to deliver a working gene into the patient’s blood cells. ,Founded in 1949 by Giovanni Stevanato, the packaging multinational is the world’s largest maker of cartridges for insulin pens and provides vials and syringes for 90% of the world’s Covid-19 vaccines.